News

Published on 21 Nov 2022 on Simply Wall St. via Yahoo Finance

Estimating The Fair Value Of Passage Bio, Inc. (NASDAQ:PASG)


Article preview image

Does the November share price for Passage Bio, Inc. (NASDAQ:PASG) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by projecting its future cash flows and then discounting them to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Don't get put off by the jargon, the math behind it is actually quite straightforward.

We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.

View our latest analysis for Passage Bio

NASDAQ.PASG price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should Know

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 8 Mar 2024

WuXi AppTec, WuXi Bio Tumble After US Panel Advances Ban Bill

(Bloomberg) -- WuXi AppTec Co. tumbled after a US Senate committee advanced a bill that may ban...

Bloomberg via Yahoo News 7 Mar 2024

Lyra (LYRA) Posts Upbeat Data on Rhinosinusitis Study, Stock Up

Lyra Therapeutics LYRA reported positive data from the ongoing phase II BEACON study, evaluating ...

Zacks via Yahoo Finance 14 Sep 2023

Passage Bio, Inc. (NASDAQ:PASG) Q4 2022 Earnings Call Transcript

Passage Bio, Inc. (NASDAQ:PASG) Q4 2022 Earnings Call Transcript March 6, 2023 Operator: Good mor...

Insider Monkey via Yahoo Finance 8 Mar 2023

Philadelphia-area public companies lost $186B in value in 2022. These were the biggest winners and...

Publicly traded companies in the region collectively lost more than $186 billion in market value...

American City Business Journals 10 Jan 2023

After losing 67% in the past year, Passage Bio, Inc. (NASDAQ:PASG) institutional owners must be...

To get a sense of who is truly in control of Passage Bio, Inc. (NASDAQ:PASG), it is important to ...

Simply Wall St. via Yahoo Finance 7 Jan 2023

15 Most Shorted Stocks Hedge Funds Are Buying

In this article, we will discuss the 15 most shorted stocks hedge funds are buying. You can skip ...

Insider Monkey via Yahoo Finance 28 Dec 2022

The 7 Best ETFs to Buy to Cover 2023’s Biggest Investing Opportunities

These are some of the best ETFs to buy and hold heading into New Year 2023. Rather than being com...

InvestorPlace via Yahoo Finance 20 Dec 2022

Passage Bio Stock Jumps After Gene Therapy Study In Lysosomal Storage Disorder

Passage Bio Inc (NASDAQ: PASG) announced new interim safety, biomarker, and clinical development ...

Benzinga via Yahoo Finance 14 Dec 2022

Estimating The Fair Value Of Passage Bio, Inc. (NASDAQ:PASG)

Does the November share price for Passage Bio, Inc. (NASDAQ:PASG) reflect what it's really worth?...

Simply Wall St. via Yahoo Finance 21 Nov 2022